Archive - February 2018
Roche’s autism drug scores FDA breakthrough status
Amgen set for Kyprolis label boost after CHMP backing
Sanofi, DNDi seek EMA review for sleeping sickness drug
NICE backs Roche’s Perjeta for breast cancer
New Mexico Democrats push allowing Medicaid buy-in coverage
Quantum chemistry solves mystery why there are these 20 amino acids in the genetic code
‘Islands’ of cell membrane components
Final NHS nod for Janssen’s Imbruvica